Simon N. Powell

Active 1980–2025

134
Papers
19,607
Citations
84
h-index
128
i10-index

Citations

Citations per year for Simon N. Powell1980: 2 citations1981: 1 citations1984: 2 citations1985: 4 citations1986: 1 citations1987: 2 citations1988: 5 citations1989: 5 citations1990: 7 citations1991: 6 citations1992: 6 citations1993: 11 citations1994: 6 citations1995: 5 citations1996: 16 citations1997: 7 citations1998: 11 citations1999: 24 citations2000: 20 citations2001: 28 citations2002: 55 citations2003: 51 citations2004: 63 citations2005: 90 citations2006: 127 citations2007: 88 citations2008: 97 citations2009: 99 citations2010: 120 citations2011: 117 citations2012: 140 citations2013: 163 citations2014: 184 citations2015: 156 citations2016: 141 citations2017: 126 citations2018: 155 citations2019: 539 citations2020: 719 citations2021: 877 citations2022: 683 citations2023: 558 citations2024: 930 citations2025: 506 citations2026: 13 citations1982–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,127 citing papers, 31.4% of this breakdownChina: 927 citing papers, 9.3% of this breakdownUnited Kingdom: 740 citing papers, 7.4% of this breakdownGermany: 507 citing papers, 5.1% of this breakdownItaly: 468 citing papers, 4.7% of this breakdownCanada: 434 citing papers, 4.4% of this breakdownFrance: 359 citing papers, 3.6% of this breakdownNetherlands: 317 citing papers, 3.2% of this breakdownAustralia: 271 citing papers, 2.7% of this breakdownJapan: 240 citing papers, 2.4% of this breakdownSpain: 225 citing papers, 2.3% of this breakdownSwitzerland: 187 citing papers, 1.9% of this breakdown
0%31.4%Other 21.6%

Fields

  • Biochemistry, Genetics and Molecular Biology45.3%
  • Medicine41.4%
  • Immunology and Microbiology7.4%
  • Computer Science2.2%
  • Physics and Astronomy1.2%
  • Engineering0.7%
  • Other1.8%

Topics

  • DNA Repair Mechanisms8.6%
  • PARP inhibition in cancer therapy4.9%
  • Cancer Genomics and Diagnostics3.5%
  • CRISPR and Genetic Engineering2.9%
  • Breast Cancer Treatment Studies2.8%
  • BRCA gene mutations in cancer2.4%
  • Other74.9%

Coauthors

All papers

Open in search
  1. Chromosomal instability drives metastasis through a cytosolic DNA response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan Lammerding, Charles Swanton, Lewis C. Cantley - Nature 2018 cited by 1,595

  2. Non-cell-autonomous cancer progression from chromosomal instability

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2023 cited by 282

  3. Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shinsan M. Su, Anusha Kalbasi, Neil Vasan, Simon N. Powell, Jedd D. Wolchok, Olivier Elemento, Charles Swanton, Alexander N. Shoushtari, Eileen E. Parkes, Benjamin Izar, Samuel F. Bakhoum - Cancer Discovery 2020 cited by 280

  4. BRCA1 and BRCA2: different roles in a common pathway of genome protection

    Authors: , , - Nature reviews. Cancer 2011 cited by 1,446

  5. Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chau T. Dang, Jeeban P. Das, Pamela Drullinsky, Julianna Eng, Jessica Flynn, Daphna Y. Gelblum, Erin F. Gillespie, Jeffrey Girshman, Daniel R. Gomez, Ayca Gucalp, David Guttmann, Carla Hajj, Daniel S. Higginson, Afsheen N. Iqbal, Atif J. Khan, Quincey LaPlant, Nancy Y. Lee, J.M. Mann, Shanu Modi, Azadeh Namakydoust, Kenneth Ng, Juber Patel, Simon N. Powell, Isabel R. Preeshagul, Isabel Preeshagul, Marsha Reyngold, Marsha Reyngold, Nadeem Riaz, Mark E. Robson, Charles M. Rudin, Rachel Sanford, Andrew D. Seidman, Ronak Shah, Narek Shaverdian, Annemarie F. Shepherd, Jacob Y. Shin, Steven Sugarman, Tiffany A. Traina, C. Jillian Tsai, Abraham J. Wu, Amy Xu, Abraham J Wu, Randy Yeh, Jonathan T Yang, Wanqing Iris Zhi, Zhigang Zhang, Wanqing Iris Zhi - The Lancet 2023 cited by 255

  6. PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer

    Authors: , , , , , , , , , , , - Clinical Cancer Research 2016 cited by 334

  7. Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nadeem Riaz, Jorge S. Reis‐Filho, Simon N. Powell, David A. Knowles, Ed Reznik, Bud Mishra, Rameen Beroukhim, Michael C. Zody, Nicolas Robine, Kenji Oman, Carissa A. Sanchez, Mary K. Kuhner, Lucian P. Smith, Patricia C. Galipeau, Thomas G. Paulson, Brian J. Reid, Xiaohong Li, David Wilkes, Andrea Sboner, Juan Miguel Mosquera, Olivier Elemento, Marcin Imieliński - Cell 2020 cited by 286

  8. Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2013 cited by 567

  9. Synthetic Lethality in Cancer Therapeutics: The Next Generation

    Authors: , , , , , , , - Cancer Discovery 2021 cited by 198

  10. A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple‐negative breast cancer

    Authors: , , , , , , , , , , , , , - Cancer 2019 cited by 194

  11. Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eileen M. O’Reilly - Clinical Cancer Research 2020 cited by 226

  12. Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cancer 2020 cited by 210

  13. Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 142

  14. Detection of Early Human Papillomavirus–Associated Cancers by Liquid Biopsy

    Authors: , , , , , , , , , , , , , , - JCO Precision Oncology 2019 cited by 127

  15. Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 116

  16. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

    Authors: , , , , , , , , , , , , , , , , , - Nature Genetics 2011 cited by 731

  17. Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 96

  18. Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James Fetten, Anuja Kripani, David G. Pfister, Alan L. Ho, Amita Shukla‐Dave, John L. Humm, Simon N. Powell, Bob T. Li, Jorge S. Reis‐Filho, Luis A. Díaz, Richard J. Wong, Nadeem Riaz - Journal of Clinical Oncology 2024 cited by 93

  19. Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric J. Moore, Joaquín J. García, Robert L. Foote, Alan L. Ho, Richard J. Wong, Timothy A. Chan, Simon N. Powell, Paul C. Boutros, John L. Humm, Amita Shukla‐Dave, David G. Pfister, Jorge S. Reis‐Filho, Nancy Y. Lee - JNCI Journal of the National Cancer Institute 2020 cited by 160

  20. Micronuclear collapse from oxidative damage

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas M. Jeitner, Samuel F. Bakhoum - Science 2024 cited by 69

  21. Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 61

  22. Rad52 inactivation is synthetically lethal with BRCA2 deficiency

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 341

  23. Most large structural variants in cancer genomes can be detected without long reads

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Genetics 2023 cited by 41

  24. Human papillomavirus 16 promotes microhomology-mediated end-joining

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 92